Acute stress alters cognitive performance, yet competing models make divergent predictions regarding the mechanisms, scope, and temporal dynamics of these effects. This large-scale randomized controlled trial tested predications from three influential stress-effect models using a broad cognitive task battery embedded within a psychopharmacological stress paradigm. Across 606 testing sessions, 303 healthy male participants completed both the Maastricht Acute Stress Test (MAST) and its non-stress control condition. To independently manipulate acute stress and stress hormone availability, participants were additionally randomized to receive atomoxetine (40 mg; to prolong norepinephrine availability), hydrocortisone (10 mg; to increase cortisol availability), or placebo. Cognitive performance was assessed over 80-minutes (post-stress) using tasks targeting visual perception (rapid serial visual presentation), response inhibition (stop-signal), and cognitive flexibility (dual and switch tasks). MAST exposure selectively impaired response inhibition, reflected in shorter stop-signal delays, lower probabilities of successful stopping and prolonged stop-signal reaction times, particularly